These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 10781652)

  • 1. Lp(a) and lipids in adult Turner's syndrome: impact of treatment with 17beta-estradiol and norethisterone.
    Gravholt CH; Christian Klausen I; Weeke J; Sandahl Christiansen J
    Atherosclerosis; 2000 May; 150(1):201-8. PubMed ID: 10781652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose metabolism, lipid metabolism, and cardiovascular risk factors in adult Turner's syndrome. The impact of sex hormone replacement.
    Gravholt CH; Naeraa RW; Nyholm B; Gerdes LU; Christiansen E; Schmitz O; Christiansen JS
    Diabetes Care; 1998 Jul; 21(7):1062-70. PubMed ID: 9653596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum lipids, lipoprotein lp(a), and plasminogen activator inhibitor-1 in patients with Turner's syndrome before and during growth hormone and estrogen therapy.
    Lanes R; Gunczler P; Palacios A; Villaroel O
    Fertil Steril; 1997 Sep; 68(3):473-7. PubMed ID: 9314917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol.
    Gravholt CH; Naeraa RW; Fisker S; Christiansen JS
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2570-7. PubMed ID: 9253336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen-progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal women.
    Tilly-Kiesi M; Kahri J; Pyörälä T; Puolakka J; Luotola H; Lappi M; Lahdenperä S; Taskinen MR
    Atherosclerosis; 1997 Mar; 129(2):249-59. PubMed ID: 9105568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced androgen levels in adult turner syndrome: influence of female sex steroids and growth hormone status.
    Gravholt CH; Svenstrup B; Bennett P; Sandahl Christiansen J
    Clin Endocrinol (Oxf); 1999 Jun; 50(6):791-800. PubMed ID: 10468952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipids and antioxidative effects of estradiol and sequential norethisterone acetate treatment in a 3-month randomized controlled trial.
    Falkeborn M; Lithell H; Persson I; Vessby B; Naessén T
    Climacteric; 2002 Sep; 5(3):240-8. PubMed ID: 12419082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of hormone replacement therapy on cardiovascular hemodynamics in women with Turner's syndrome.
    Elsheikh M; Bird R; Casadei B; Conway GS; Wass JA
    J Clin Endocrinol Metab; 2000 Feb; 85(2):614-8. PubMed ID: 10690864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).
    Hartgens F; Rietjens G; Keizer HA; Kuipers H; Wolffenbuttel BH
    Br J Sports Med; 2004 Jun; 38(3):253-9. PubMed ID: 15155420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term treatment with growth hormone has no persisting effect on lipoprotein(a) in patients with Turner's syndrome.
    Querfeld U; Döpper S; Gradehand A; Kiencke P; Wahn F; Zeisel HJ
    J Clin Endocrinol Metab; 1999 Mar; 84(3):967-70. PubMed ID: 10084580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lipoprotein a (Lp(a)) in patients with Turner's syndrome].
    Wikiera B; Bieniasz J; Barg E; Głab E; Noczyńska A
    Pediatr Endocrinol Diabetes Metab; 2010; 16(1):29-32. PubMed ID: 20529603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel intermittent regimen of norgestimate to preserve the beneficial effects of 17beta-estradiol on lipid and lipoprotein profiles.
    Lobo RA; Zacur HZ; Caubel P; Lane R
    Am J Obstet Gynecol; 2000 Jan; 182(1 Pt 1):41-9. PubMed ID: 10649155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of oral and transdermal hormone replacement therapy on lipid profile and Lp(a) level in menopausal women with hypercholesterolemia.
    Perrone G; Stefanutti C; Galoppi P; Anelli G; Capri O; Lucani G; Vivenzio A; Mazzarella B; Zichella L
    Int J Fertil Menopausal Stud; 1996; 41(6):509-15. PubMed ID: 9010744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exaggerated effects of progestogen on uterine artery pulsatility index in Turner's syndrome patients receiving hormone replacement therapy.
    Biljan MM; Taylor CT; Matijevic R; Jones SV; Garden AS; Fraser WD; Diver MJ; Kingsland CR
    Fertil Steril; 1995 Dec; 64(6):1104-8. PubMed ID: 7589660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum T3, T4, FT3, TSH and TBG in Turner's syndrome].
    De Felice C; Anichini C; Mattei R; Berardi R; Scarinci R; Vivarelli R; Bagnoli F
    Boll Soc Ital Biol Sper; 1991 Jul; 67(7):681-5. PubMed ID: 1818593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral 17beta-estradiol (1 mg) continuously combined with dydrogesterone improves the serum lipid profile of postmenopausal women.
    Pornel B; Chevallier O; Netelenbos JC
    Menopause; 2002; 9(3):171-8. PubMed ID: 11973440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of obesity on cardiovascular risk factors in Turner's syndrome.
    Elsheikh M; Conway GS
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):447-50. PubMed ID: 9876341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in serum lipoprotein(a) and lipids during treatment of hyperthyroidism.
    Kung AW; Pang RW; Lauder I; Lam KS; Janus ED
    Clin Chem; 1995 Feb; 41(2):226-31. PubMed ID: 7874776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential atherogenic roles of lipids, lipoprotein(a) and lipid peroxidation in preeclampsia.
    Bayhan G; Koçyigit Y; Atamer A; Atamer Y; Akkus Z
    Gynecol Endocrinol; 2005 Jul; 21(1):1-6. PubMed ID: 16048794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.